BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9767610)

  • 1. T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1.
    Sentongo E; Rubaale T; Büttner DW; Brattig NW
    Parasite Immunol; 1998 Sep; 20(9):431-9. PubMed ID: 9767610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.
    Soboslay PT; Geiger SM; Drabner B; Banla M; Batchassi E; Kowu LA; Stadler A; Schulz-Key H
    Clin Exp Immunol; 1999 Jul; 117(1):130-7. PubMed ID: 10403926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
    Soboslay PT; Lüder CG; Riesch S; Geiger SM; Banla M; Batchassi E; Stadler A; Schulz-Key H
    Immunology; 1999 Jun; 97(2):219-25. PubMed ID: 10447735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.
    Lüder CG; Schulz-Key H; Banla M; Pritze S; Soboslay PT
    Clin Exp Immunol; 1996 Aug; 105(2):245-53. PubMed ID: 8706329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density.
    Brattig NW; Lepping B; Timmann C; Büttner DW; Marfo Y; Hamelmann C; Horstmann RD
    J Infect Dis; 2002 Apr; 185(8):1148-54. PubMed ID: 11930325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
    Soboslay PT; Geiger SM; Weiss N; Banla M; Lüder CG; Dreweck CM; Batchassi E; Boatin BA; Stadler A; Schulz-Key H
    Immunology; 1997 Apr; 90(4):592-9. PubMed ID: 9176114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory effects of IL-12 and IL-18 on Onchocerca volvulus- and Entamoeba histolytica-specific cellular reactivity and cytokine profiles.
    Pfaff AW; Kirch AK; Hoffmann WH; Banla M; Schulz-Key H; Geiger SM; Soboslay PT
    Parasite Immunol; 2003 Jun; 25(6):325-32. PubMed ID: 14507330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune responses in human infection with Onchocerca volvulus.
    Gallin M; Edmonds K; Ellner JJ; Erttmann KD; White AT; Newland HS; Taylor HR; Greene BM
    J Immunol; 1988 Mar; 140(6):1999-2007. PubMed ID: 3257994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
    Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
    Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response.
    Cooper PJ; Mancero T; Espinel M; Sandoval C; Lovato R; Guderian RH; Nutman TB
    J Infect Dis; 2001 Jun; 183(11):1662-8. PubMed ID: 11343216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human infection with Onchocerca volvulus does not affect the T helper cell phenotype of the cellular immune response to mycobacterial antigen.
    Cooper PJ; Guderian RH; Nutman TB; Taylor DW
    Trans R Soc Trop Med Hyg; 1997; 91(3):350-2. PubMed ID: 9231215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.
    Doetze A; Satoguina J; Burchard G; Rau T; Löliger C; Fleischer B; Hoerauf A
    Int Immunol; 2000 May; 12(5):623-30. PubMed ID: 10784608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human immune responses to the cytosolic superoxide dismutase and glutathione S-transferase from Onchocerca volvulus.
    Brattig NW; Henkle-Dührsen KH; Hounkpatin S; Liebau E; Kruppa TF; Zipfel PF
    Trop Med Int Health; 1997 Aug; 2(8):788-98. PubMed ID: 9294549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerciasis modulates the immune response to mycobacterial antigens.
    Stewart GR; Boussinesq M; Coulson T; Elson L; Nutman T; Bradley JE
    Clin Exp Immunol; 1999 Sep; 117(3):517-23. PubMed ID: 10469056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental onchocerciasis in chimpanzees: cellular responses and antigen recognition after immunization and challenge with Onchocerca volvulus infective third-stage larvae.
    Lüder CG; Soboslay PT; Prince AM; Greene BM; Lucius R; Schulz-Key H
    Parasitology; 1993 Jul; 107 ( Pt 1)():87-97. PubMed ID: 8356001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of both IFN-gamma and IL-5 by Onchocerca volvulus S1 antigen-specific CD4+ T cells from putatively immune individuals.
    Doetze A; Erttmann KD; Gallin MY; Fleischer B; Hoerauf A
    Int Immunol; 1997 May; 9(5):721-9. PubMed ID: 9184917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states.
    Brattig N; Nietz C; Hounkpatin S; Lucius R; Seeber F; Pichlmeier U; Pogonka T
    J Infect Dis; 1997 Sep; 176(3):838-42. PubMed ID: 9291349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection.
    Soboslay PT; Dreweck CM; Taylor HR; Brotman B; Wenk P; Greene BM
    J Immunol; 1991 Jul; 147(1):346-53. PubMed ID: 2051025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.